Metronidazole Injection Shortage: Latest Updates on Availability and Manufacturer Status
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA reports an ongoing shortage of Metronidazole Injection, an anti-infective medication. While some supply remains available, the shortage status is currently active.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Metronidazole.
What's in Shortage
Metronidazole Injection, a medication in the anti-infective therapeutic category, is currently listed as being in shortage. This shortage affects the injection dosage form, specifically the 500 mg/100 mL presentation. Brand names associated with this medication include METRONIDAZOLE and Flagyl I.v. Rtu.
Which Manufacturers Are Affected
According to the FDA database, the following manufacturer information is available:
- Baxter Healthcare: Currently listed as "Available."
- Presentation: Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)
- Contact Information: 888-229-0001
Why There's a Shortage
The source data does not provide a specific reason for the current shortage of Metronidazole Injection.
What Patients Should Do
If you are a patient who requires Metronidazole Injection, it is important to stay informed about supply levels. We recommend the following steps:
- Consult your healthcare provider: Discuss your treatment plan and ask about the availability of the medication at your treatment facility.
- Speak with a pharmacist: Pharmacists often have the most up-to-date information on local stock and can coordinate with suppliers.
- Contact the manufacturer: You may use the contact information provided above to inquire about supply timelines.
Disclaimer: Patients should always consult with their healthcare provider or a qualified medical professional regarding their treatment and any potential changes to their medication regimen.
Source
Information for this report is attributed to the FDA Drug Shortage Database.
- Initial Posting Date: 01/13/2022
- Last Updated: 02/02/2026
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.